MetaCap

Abeona Therapeutics (ABEO) vs SIGA Technologies (SIGA)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Abeona Therapeutics (ABEO) has outperformed SIGA Technologies (SIGA) over the past year, losing 46.0% versus a loss of 58.9%. Over five years, SIGA leads with a -71.9% price change compared with -86.7% for ABEO. SIGA Technologies is the larger company by market cap ($172.5 million vs $165.3 million), about 1.0 times the size.

Abeona Therapeutics converts more of its revenue into profit, with a net margin of 1223.1% versus 24.6%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ABEO-45.98%SIGA-58.90%
+73%+4%-65%
Nov 21, 20251 yearNov 20, 2026
ABEO-86.92%SIGA-74.08%
+180%+40%-101%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ABEO versus SIGA key metrics
MetricABEOSIGA
Share price$2.42$2.40
Market cap$165.31M$172.45M
1-day change-1.22%-9.43%
YTD return-54.08%-60.72%
1-year return-45.98%-58.90%
5-year return-86.74%-71.90%
P/E ratio (TTM)—240.00
Forward P/E—5.45
EPS (TTM)$-1.16$0.01
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$5.82M$94.57M
Revenue growth (YoY)—-31.82%
Net income (latest FY)$71.18M$23.28M
Gross margin73.68%68.59%
Operating margin-1536.91%25.06%
Net margin1223.08%24.61%
52-week high$7.65$7.11
52-week low$2.09$2.30
Distance from 52-week high-68.37%-66.24%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+542.98%+35.42%
Average volume1.66M617.60K
Shares outstanding68.31M71.86M
Employees22649
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • ABEO has outperformed SIGA by 12.9 percentage points over the past year.
  • Abeona Therapeutics is more profitable, keeping 1223.1 cents of every revenue dollar as net income versus 24.6 cents for SIGA Technologies.

About Abeona Therapeutics

ABEO stock →

Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa.

Health Care · Biotechnology: Pharmaceutical Preparations · 226 employees

About SIGA Technologies

SIGA stock →

SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus.

Health Care · Biotechnology: Pharmaceutical Preparations · 49 employees

ABEO vs SIGA FAQ

Which is bigger, Abeona Therapeutics or SIGA Technologies?

SIGA Technologies (SIGA) is larger, with a market capitalization of $172.45M compared with $165.31M for Abeona Therapeutics (ABEO).

Which stock has performed better over the past year, ABEO or SIGA?

ABEO returned -45.98% over the past 12 months, compared with -58.90% for SIGA (price return, excluding dividends). Past performance does not predict future results.

Are Abeona Therapeutics and SIGA Technologies in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons